Kai-Yuan Chen

Kai-Yuan Chen

Company: Scribe Therapeutics

Job title: Director, Data Science & Tech Platform


Developing a Framework for Off-Target Prediction & Detection 11:00 am - 1:00 pm

Summarizing the most popular methods for off-target nomination and detection: their relative strengths and weaknesses What should I consider when choosing, and how do they complement bioinformatic nomination? Using appropriate read depth and window size to generate high assay sensitivities Within the current regulatory context, how can these tools be applied for the risk assessment…Read more

day: Pre-Conference Workshop Day

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.